These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2119517)

  • 1. [Physiologic function of oncogene products: the expression of proto-oncogenes in cellular proliferation and differentiation in normal tissues and the general mechanism of their transcription].
    Liu PN
    Sheng Li Ke Xue Jin Zhan; 1990 Apr; 21(2):112-8. PubMed ID: 2119517
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of proto-oncogenes in fundamental manifestations of life].
    Seĭts IF
    Eksp Onkol; 1990; 12(6):14-26. PubMed ID: 1702050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic interaction between Rb and N-ras: differentiation control and metastasis.
    Takahashi C; Ewen ME
    Cancer Res; 2006 Oct; 66(19):9345-8. PubMed ID: 17018584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ras p21 and signal transduction].
    Kishi K; Tanaka K; Takai Y
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1107-21. PubMed ID: 8512342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral-mediated gene transfer of a mutant H-ras gene into normal human bone marrow alters myeloid cell proliferation and differentiation.
    Maher J; Colonna F; Baker D; Luzzatto L; Roberts I
    Exp Hematol; 1994 Jan; 22(1):8-12. PubMed ID: 8282064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
    Pichon F; Seuwen K; Pouysségur J; Lagarde AE
    Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of proto-oncogene induction from growth response in normal human fibroblasts.
    Yaar M; Peacocke M; Cohen MS; Gilchrest BA
    J Cell Physiol; 1990 Oct; 145(1):39-45. PubMed ID: 2120243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenes and uterine function.
    Stancel GM; Baker VV; Hyder SM; Kirkland JL; Loose-Mitchell DS
    Oxf Rev Reprod Biol; 1993; 15():1-42. PubMed ID: 8336974
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
    Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
    Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineating v-Src downstream effector pathways in transformed myoblasts.
    Ciuffini L; Castellani L; Salvati E; Galletti S; Falcone G; Alemà S
    Oncogene; 2008 Jan; 27(4):528-39. PubMed ID: 17637741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S; Capobianco AJ; Gilmore TD
    Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
    Bortner DM; Langer SJ; Ostrowski MC
    Crit Rev Oncog; 1993; 4(2):137-60. PubMed ID: 8380545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function.
    Katzav S; Packham G; Sutherland M; Aroca P; Santos E; Cleveland JL
    Oncogene; 1995 Sep; 11(6):1079-88. PubMed ID: 7566967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis and secondary expression profiling of candidate genes deregulated in conjunction with oncogenic Ras signaling.
    Raudies O; Kuban RJ; Hamacher F; Klein-Hitpass L; Tchernitsa OI; Sers C; Herzel HP; Schäfer R
    Adv Enzyme Regul; 2005; 45():63-84. PubMed ID: 16023704
    [No Abstract]   [Full Text] [Related]  

  • 18. Oncogene mediated repression of glucocorticoid hormone response elements and glucocorticoid receptor levels.
    Jaggi R; Höck W; Ziemiecki A; Klemenz R; Friis R; Groner B
    Cancer Res; 1989 Apr; 49(8 Suppl):2266s-2274s. PubMed ID: 2564809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
    Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G
    Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.